SCHEMBL15081033

SCHEMBL15081033

CC(=O)c1ccc(C2CCCCCCCCCCCCCCC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.59
HDAC6 Q9UBN7 2/20 0.59
HDAC1 Q13547 1/20 0.59
HAO1 Q9UJM8 1/20 0.56
DEGS1 O15121 2/20 0.53
HDAC3 O15379 1/20 0.53
HDAC11 Q96DB2 1/20 0.53
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
EPHX1 P07099 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
ALDH1A1 P00352 2/20 0.49
MAPT P10636 1/20 0.49
KMO O15229 1/20 0.47
NAMPT P43490 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GLA P06280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15905969 1.00 HDAC8 (0.59) HDAC8HDAC6HDAC1HAO1DEGS1
SCHEMBL13445251 1.00 HDAC8 (0.59) HDAC8HDAC6HDAC1HAO1DEGS1
SCHEMBL28595922 1.00 HDAC8 (0.59) HDAC8HDAC6HDAC1HAO1DEGS1
SCHEMBL14231550 1.00 HDAC8 (0.59) HDAC8HDAC6HDAC1HAO1DEGS1
SCHEMBL6822733 1.00 HDAC8 (0.59) HDAC8HDAC6HDAC1HAO1DEGS1
SCHEMBL967133 1.00 HDAC8 (0.59) HDAC8HDAC6HDAC1HAO1DEGS1
SCHEMBL6822864 1.00 HDAC8 (0.59) HDAC8HDAC6HDAC1HAO1DEGS1
SCHEMBL12337677 1.00 HDAC8 (0.59) HDAC8HDAC6HDAC1HAO1DEGS1
SCHEMBL469036 0.98 HDAC8 (0.61) HDAC8HDAC6HDAC1HAO1DEGS1
SCHEMBL11136357 0.94 HDAC8 (0.54) HDAC8HDAC6HDAC1HAO1DEGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828224-B1 COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES AMBRX INC (US) 2016-04-06 EP disclosed
US-20150152159-A1 MODIFIED BOVINE SOMATOTROPIN POLYPEPTIDES AND THEIR USES AMBRX INC (US) 2015-06-04 US disclosed
US-20150094457-A1 COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES AMBRX, INC. (US) 2015-04-02 US disclosed
US-8476411-B2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides AMBRX, INC. (US) 2013-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152159-A1 MODIFIED BOVINE SOMATOTROPIN POLYPEPTIDES AND THEIR USES CRH, PTMS, CRHBP HDAC8 3497/4885HDAC6 1752/4885HDAC1 4049/4885
US-20150094457-A1 COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES PTMS, DAO, DNPEP HDAC8 3647/4885HDAC6 2727/4885HDAC1 4330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.